Find participating medical centers and current study status in each of them

    Find participating medical centers

    A study of tiragolumab in combination with atezolizumab plus pemetrexed and carboplatin/cisplatin versus pembrolizumab plus pemetrexed and carboplatin/cisplatin in patients with previously untreated advanced non-squamous non-small cell lung cancer

    A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

    • Cancer
    • Lung Cancer
    • Non-Small Cell Lung Cancer (NSCLC)

    For the latest version of this information please go to www.forpatients.roche.com